These stapled peptides have potential as a therapeutic for COVID-19 by functioning as a decoy of the ACE2 binding site for SARS-CoV-2 and preventing the virus from binding to the ACE2 receptor, thereby preventing virus entry and infection. The gene discussed is ACE2; the disease is infection.